Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo's Latest $3.4 Billion Charge Over Avandia Reveals Costs of Misbehavior
Seeking Alpha
Wednesday, January 19, 2011 - 10:34am
tags:
Avandia, GSK
Protagonist Therapeutics, Ironwood sign peptide drug deal
Bizjournals.com
Wednesday, January 19, 2011 - 10:32am
tags:
peptides, Protagonist Therapeutics, Ironwood
Nektar Therapeutics plans stock sale
Bizjournals.com
Wednesday, January 19, 2011 - 9:09am
tags:
Nektar, stock offering
Can Johnson & Johnson Get Its Act Together?
NY Times, NY
Wednesday, January 19, 2011 - 9:08am
tags:
recalls, JNJ
Depomed Dives on Drug Marketing Dispute
TheStreet.com
Wednesday, January 19, 2011 - 9:08am
tags:
Depomed, shingles, Abbott Laboratories, DM-1796
Ariad Gains Most in 18 Months on Cancer Drug Results
Bloomberg
Wednesday, January 19, 2011 - 9:07am
tags:
sarcoma, Ariad Pharmaceuticals, ridaforolimus
Will Vilazodone Gain FDA Approval This Week?
Motley Fool
Tuesday, January 18, 2011 - 4:21pm
tags:
FDA, Vilazodone, Clinical Data, depression, antidepressants
Negative Outlook for Big Pharma in 2011 as Patents Expire
Seeking Alpha
Tuesday, January 18, 2011 - 4:20pm
tags:
patents, Big Pharma, JNJ, Eli Lilly, Merck, Bristol-Myers Squibb
Biosimilars: Empty Threats?
InVivo
Tuesday, January 18, 2011 - 11:58am
tags:
biosimilars, Novartis, Sandoz, Roche, Rituxan
Cephalon Goes Clubbing And Pays For Fire Eaters
Pharmalot
Tuesday, January 18, 2011 - 11:57am
tags:
Cephalon, UK, physician gifts
REGN's Pipeline Advances
Yahoo/Zacks.com
Tuesday, January 18, 2011 - 11:55am
tags:
Regeneron, Bayer, VEGF Trap-Eye
Ziopharm Oncology's Global Strategy Provides Potential Upside for Investors
Seeking Alpha
Tuesday, January 18, 2011 - 11:29am
tags:
Ziopharm, ifosfamide
What's Next for Shares of Corcept Therapeutics
Minyanville
Tuesday, January 18, 2011 - 11:28am
tags:
Corcept Therapeutics, Cushing's syndrome
Sanofi May Raise Genzyme Bid to $75, Plus CVR Payment, RBC Says
Bloomberg
Tuesday, January 18, 2011 - 11:26am
tags:
Sanofi, CVRs, Genzyme, M&A
Cadence Pharma starts selling IV pain drug Ofirmev
Yahoo/AP
Tuesday, January 18, 2011 - 11:24am
tags:
Cadence Pharmaceuticals, Ofirmev, IV pain medication
Alexza shares tumble on FDA setback
Marketwatch
Tuesday, January 18, 2011 - 11:21am
tags:
Alexza, FDA, AZ-004, bipolar disorder, schizophrenia
Forest Labs raises outlook after 3Q profit rises
Yahoo/AP
Tuesday, January 18, 2011 - 11:19am
tags:
earnings, Forest Labs
Johnson & Johnson Offers Good Value With a Margin of Safety
Seeking Alpha
Tuesday, January 18, 2011 - 11:19am
tags:
JNJ
Former Merck Rep Wins Lawsuit Over Retaliation
Pharmalot
Tuesday, January 18, 2011 - 10:55am
tags:
Merck, drug reps, lawsuits
Lilly Imaging Drug Isn’t Ready for Approval, FDA Says
Bloomberg
Tuesday, January 18, 2011 - 10:54am
tags:
FDA, Eli Lilly, imaging, Alzheimer's disease, florbetapir

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.